The campaign to use magic mushrooms in OCD treatment
Orchard OCD held a global call for research ideas to create new therapies last year. Professor David Nutt’s psilocybin project was selected as the winner. Psilocybin is the psychoactive ingredient in magic mushrooms. Jacobs, from King’s College London and the University of Oxford, says it is surprising how little focus has been on the therapeutic potential of psilocybin in treating OCD, and he points to a number of new clinical trials that are finally exploring this promising treatment.
According to a study published in the World Journal of Psychiatry, even though people undergo successful OCD therapies, their OCD is not actually treated.
Although some people benefit from current therapies, others are left wondering if they will be able to recover from this chronic illness.
High psilocybin’s effectiveness has already been shown by research conducted in 2006 in the US but unfortunately, this research was never taken further. The study’s lead researcher commented that the biggest obstacle was the stigmatization of psychedelic drugs. In many countries, magic mushrooms are falsely considered to be dangerous which means psilocybin is subject to the tightest regulation. Magic mushrooms are the safest “recreational” drug to take and those who take them are the most sensible and well prepared, according to the 2017 Global Drug Survey and a team of leading scientists.